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Kinins, universal mediators of inflammation, are recognized by two kinds of receptors, B1 and 
B2, which have been found to be expressed in numerous cell types of several species. However, 
the knowledge of the regulation of these receptors in leukocytes is still not satisfactory. In the 
current work, we have demonstrated a constitutive production of B2 receptor mRNA in the hu-
man promonocyte U937 cells and its two-fold augmentation after cell differentiation with retinoic 
acid and phorbol ester. Bradykinin and des-Arg10-kallidin induced the expression of both B2 and 
B1 receptors in cells before and after differentiation. Generally, the undifferentiated cells were 
more susceptible to bradykinin-dependent induction of kinin receptors (increases by approxi-
mately 250% and 200% for B2 and B1 receptors, respectively). The induction, by approx. 200%, of 
B1 receptor by des-Arg10-kallidin was detected on both mRNA and protein levels. In addition, an 
unexpected strong induction of B2 receptor by this compound was observed in the retinoic acid- 
and phorbol ester-differentiated cells (by 150% and 200%, respectively) that suggests a possible 
autoregulation of kinin receptors by own agonists during the inflammatory state. On the other 
hand, a strong enhancement of the expression of both receptors by interleukin 1β, especially in 
the phorbol ester-differentiated cells, indicates the involvement of kinin receptors in the propa-
gation of the inflammatory processes.
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INTROdUcTION
Inflammation occurs as a cellular response to 
infection or tissue injury. During the inflammatory 
processes the immune system engages several cells, 
such as macrophages, neutrophils, dendritic cells 
and natural killer cells, to eliminate microbes or ir-
ritants and to potentiate tissue repair. Kinins, short-
lived peptides produced from kininogens, are known 
as important mediators of inflammation which can 
modulate the majority of events observed during in-
flammation, including vasodilatation, increased vas-
cular permeability or pain (Kozik et al., 1998; Calixto 
et al., 2000; Cassim et al., 2002; Imamura et al., 2002; 
Joseph & Kaplan, 2005). Kinins, bradykinin (BK) and 
kallidin (KD), are generated from kininogens by kal-
likreins in plasma or in peripheral tissues (Bhoola et 
al., 1992; Joseph & Kaplan, 2005). Once formed, these 
peptides can be quickly degraded by numerous 
peptidases, called kininases. Kinin-related peptides 
are recognized by two distinct types of G-coupled 
receptors: B1 (B1R) and B2 (B2R) (Bhoola et al., 1992; 
Leeb-Lundberg et al., 2005). The latter is specific for 
full-length kinins (BK and KD) whereas the B1R 
shows a high affinity for active kinin metabolites: 
des-Arg10-kallidin (DAKD) and des-Arg9-bradykinin. 
These receptors differ not only in the pharmacologi-
cal agonist profile but also in the type and regulation 
of expression. The B2R is constitutively expressed 
in the majority of healthy tissues and can be regu-
lated mainly by desensitization, internalization and 
resensitization. In contrast, B1R is generally induc-
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ible and is overexpressed in injured tissues during 
several pathologies including inflammation (Bhoola 
et al., 1992; Marceau et al., 1998; Leeb-Lundberg et 
al., 2005). The induction of B1R expression is regu-
lated mainly by cytokines, e.g. interleukin-1β (IL-1β) 
or tumor necrosis factor alpha (TNF-α) (Haddad et 
al., 2000; Phagoo et al., 2001). 
Due to the enhanced kinin occurrence in many 
disease states, the expression of kinin receptors and 
its regulation have been widely investigated in di-
verse types of cells, mainly in those involved in the 
vascular system, such as endothelial cells, smooth 
muscle cells and various blood cells (Mathis et al., 
1996; Bockmann & Paegelow, 2000; Ehrenfeld et al., 
2006; McLean et al., 2000). Taking into consideration 
the involvement of kinins in inflammatory respons-
es, many researchers have focused their interest on 
the effects of these peptides directly in leukocytes, 
mainly in neutrophils (Rajasekariah et al., 1997; 
Bockmann & Paegelow, 2000; Ehrenfeld et al., 2006; 
Bertram et al., 2007). These observations concern the 
cellular responses, such as the increase of intracel-
lular Ca2+, chemotaxis or superoxide radical produc-
tion (Bockmann et al., 1992; Bockmann & Paegelow, 
1995; Ehrenfeld et al., 2006; Bertram et al., 2007). 
However, knowledge of kinin receptor expression 
and regulation in leukocytes is not complete. In ad-
dition, in the case of mononuclear blood cells such 
as monocytes and macrophages, these observations 
are limited and difficult to interpret due to a high 
heterogeneity of these cells. They form a dynamic 
population of cells that can appear on several stages 
of differentiation and maturation and can be activat-
ed to diverse degrees with changes in their receptor 
expression and functional response (Rutherford et 
al., 1993). In this regard, in this study we chose the 
human promonocytic cell line U937 for kinin recep-
tor analysis. At resting state, this cell line presents 
a monoblastic morphology and histochemical profile 
similar to the monocytic lineage (Harris & Ralph, 
1985). The U937 cells are assumed to be a good 
model for immune response investigation (Harris & 
Ralph, 1985; Cavender et al., 1991) and can be dif-
ferentiated into monocyte/macrophage stage with 
agents such as retinoic acid (RA) or phorbol 12-myr-
istate-13-acetate (PMA). The majority of studies on 
kinin receptor expression in mononuclear cells has 
been performed in differentiated cells (e.g. perito-
neal, alveolar and foamy macrophages, or microglia) 
from different species (Bockmann & Paegelow, 2000) 
while in human monocytes only a weak expression 
of B2R has been demonstrated and B1R expression 
has not been investigated at all. 
Taking into consideration our recent findings 
of the binding of kinin progenitors by the U937 cell 
line (Barbasz et al., 2008), in this work we used these 
cells, undifferentiated or after differentiation with RA 
or PMA, as a model system to study the changes of 
kinin-receptor expression caused by BK and DAKD, 
the strongest agonists of B2R and B1R, respectively. 
The mediatory role of kinins in several pro-inflam-
matory processes has been confirmed, therefore in 
this work we also analyzed the regulation of these 
receptors by one of the major cytokines, IL-1β. In-
terestingly, the kinin receptors have been recognized 
as drug targets (Leeb-Lundberg et al., 2005; Labudda 
et al., 2007). Therefore, our observations, indicating 
an up-regulation of kinin receptors by agonists and 
IL-1β, could be important in the field of drug devel-
opment for several pathophysiological events related 
to inflammation. 
MATeRIAls ANd MeTHOds
Materials. Bovine serum albumin (BSA) was 
obtained from Amresco (USA), DAKD from BaChem 
(Germany), captopril and o-phenantroline from 
Fluka (Switzerland), fetal bovine serum (FBS) from 
Gibco (USA), and RPMI medium, phosphate buff-
ered saline (PBS), antibiotics and antimycotics from 
PAA (Austria). Bacitracin, bradykinin, IL-1β, PMA, 
and RA were purchased from Sigma (USA). Other 
chemical reagents were supplied by POCh (Poland).
cell culture and differentiation. The U937 
cells were cultured in Hepes-stabilized RPMI me-
dium supplemented with 10% FBS, 100 U/ml peni-
cillin, 0.1 mg/ml streptomycin and 2.5 µg/ml am-
photericin B for 5 days in a humidified atmosphere 
containing 5% CO2 at 37oC. For differentiation, the 
cells were suspended in 2% FBS medium with 1 µM 
RA or 25 nM PMA for 1 day. Next, the cells were 
incubated for 3 days in 2% FBS medium before the 
experiments were carried out.
determination of the mRNA expression for 
selected genes. Cells (2.5 × 106), either undifferenti-
ated or after differentiation, were incubated with 
BK or DADK at 1 nM concentration for up to 5 h in 
RPMI medium supplemented with kininase inhibi-
tors (20 µM captopril, 100 µM o-phenantroline and 
500 µM bacitracin). Similar experiments were per-
formed with 10 ng/ml IL-1β. After incubation, the 
total RNA was isolated from cells with Total RNA 
Isolation System (Promega, USA). The B1R, B2R and 
IL-1β gene expression was analyzed with a two step 
RT-PCR procedure. The GAPDH mRNA expression 
was measured in every sample for a semiquantita-
tive analysis. First, the cDNA was synthesized with 
Super Script II Rnase H-Reverse Transcriptase (In-
vitrogen, USA) according to the manufacturer’s in-
struction and with 10 µM dT oligomers. Next, the 
amplification of cDNA (2 µl) by PCR was performed 
in a 25 µl reaction mixture with Taq polymerase 
(Finnzymes, Finland), 0.1 mM dNTP (Fermentas, 
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Canada) and 0.2 µM specific primers. The primer 
pair sequences were: 5’ ctttcctatgggatgaagatat 3’ and 
5’ ttcttattccaggtgcaagcag 3’ for B1R, 5’ cacggtgctagtc-
ctggttgtgct 3’ and 5’ aggtccgcagtgtgcccatg 3’ for B2R, 
5’ gatgtctggtccatatgaactg 3’ and 5’ ttgggatctacactctc-
cagc 3’ for IL-1β, and 5’ tctagacggcaggtcaggtccacc 3’ 
and 5’ ccacccatggcaaattccatggca 3’ for GAPDH (Oli-
go.pl, Poland). The annealing temperature for B1R, 
B2R, IL-1β and GADPH was 62oC, 71oC, 62oC and 
70oC, respectively. The PCR conditions included an 
initial denaturation step of 5 min at 95oC, followed 
by 35 cycles (30 s denaturation at 95oC, 30 s of prim-
er annealing at the appropriate temperature, 30 s at 
72oC) and one cycle of 10 min for cDNA extension 
at 72oC. The PCR products for B1R, B2R, IL-1β and 
GAPDH gene, resolved on 1% agarose gels contain-
ing ethidium bromide for ultraviolet detection, were 
214 bp, 314 bp, 210 bp and 598 bp, respectively. 
Analysis of B1R protein by immunocyto-
chemistry. PMA-differentiated cells (2 × 105), after 
stimulation with 1 nM BK or DAKD and 10 ng/ml 
IL-1β or with the peptides in the presence IL-1β, 
were attached to a glass coverslide by cytospin. 
Next, the cells were fixed with 100% cold methanol 
and incubated with 1% BSA. After 40-min blocking, 
the cells were incubated overnight at 4oC with rab-
bit anti-human B1 receptor antibody (Abcam, UK) at 
1 : 50 dilution in PBS supplemented with 0.5% BSA. 
After 3-fold washing, the fixed cells were treated 
with a secondary antibody, FITC-labeled goat anti-
rabbit IgG (Abcam, UK) at 1 : 250 dilution in PBS 
for 1 h at room temp. in the dark. The coverslide 
mounting with microscope slides was preceded by 
extensive washing with PBS and distilled water. The 
antibody-labeled cells were analyzed with epifluo-
rescence DM IRE2 microscope (Leica, Germany). A 
negative control probe was prepared omitting the 
first antibody incubation.
Quantitative image analysis. For a semiquan-
titative analysis of RT-PCR, the gel-band intensity 
of the PCR products was measured by densitome-
try with Fluor-S MultiImager (BioRad Laboratories, 
USA) and Quantity One software. The intensity of 
the PCR product band of every investigated probe 
was divided by the intensity of GAPDH PCR prod-
uct band. The results are presented as the percent-
age of the cell response to stimulation as compared 
with unstimulated cells. 
The fluorescent intensity of B1R-bound FITC-
labeled antibody in the studied samples was quanti-
fied using ImageJ software. The measured area was 
selected with “brightness slicing” procedure with a 
constant lower threshold value. The mean area was 
measured as the sum of the gray values of all pixels 
in the selection and then divided by the number of 
pixels. The mean area value for the negative control 
was subtracted from the positively labeled slides. 
The resulting value represents the net signal intensi-
ty derived from specific immunolabeled probes. The 
intensities of three different images on each slide 
were averaged.
statistical analysis. All values were presented 
as means ± S.D. of at least three experiments. Data 
were analyzed by Student’s t-test and the differences 
were judged to be significant at P < 0.05.
ResUlTs
The U937 cells were analyzed for basal B2R 
and B1R mRNA production before and after dif-
ferentiation with RA or PMA. According to pre-
vious reports, the obtained monocyte-like cells af-
ter RA treatment were non-adherent and showed 
only insignificant proliferation while phorbol es-
ters caused changes in adherence and induced a 
macrophage-like morphology (Honma et al., 1980; 
Harris & Ralph, 1985). In this study, the undif-
ferentiated cells unquestionably showed a clear 
expression of the B2R gene (Fig. 1) that was en-
hanced by RA or PMA treatment by 2- and 1.7-
fold, respectively. The B1R expression was lower 
than that of B2R. The incubation with RA aug-
mented the production of mRNA of this receptor 
(two-fold) while no significant effect of PMA on 
B1R gene expression was observed.
The mean value of kinins in normal human 
plasma is reported to be in the picomolar range 
(Blais et al., 2000). We chose 1 nM kinin concentra-
tion to analyze their effects on the regulation of ki-
nin receptor expression, assuming that the applied 
concentration approaches the pathological levels of 
these inflammatory mediators. A clear, strong up-
regulatory effect of BK on kinin receptor genes was 
observed (Fig. 2). In the undifferentiated U937 cells, 
BK caused a time-dependent increase in mRNA ex-
pression of the B2R with a maximum after 3 h (above 
250%) (Fig. 2A). After 5-h incubation with this kinin, 
the amount of B2R mRNA decreased nearly to the 
initial value. A similar but faster effect was observed 
for the differentiated cells, with a maximal cell re-
sponse after two hours (Fig. 2B). The RA-differen-
tiated cells showed a somewhat stronger response 
as compared to PMA-treated cells (by 230% versus 
160%) and these increases were significant compared 
to unstimulated cells. BK was able to stimulate not 
only the increase of B2R mRNA but also the mRNA 
of the second kinin receptor, B1R. This effect was 
also time-dependent and the maximal increase was 
obtained after 2-h incubation. In general, the amount 
of induced mRNA for B1R was lower as compared 
with B2R expression. The highest cell response was 
observed in undifferentiated cells and did not ex-
ceed 200% while the increase observed in differen-
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tiated cells was not significant in comparison with 
unstimulated cells (Fig. 2C).
The second agonist used, DAKD, exhibits 
a high affinity to B1 receptor. The analysis of the 
results obtained from the incubation of undifferen-
tiated cells with DAKD indicates a time-depend-
ent up-regulation of B1R mRNA that achieved the 
maximal cell response at 2 h with a value above 
200% as compared to unstimulated cells (Fig. 3A). 
A similar effect was observed in RA-differentiated 
cells after stimulation with 1 nM DAKD (Fig. 3A). 
The results obtained for PMA-differentiated cells, 
stimulated with 1 nM DAKD, were not consistent; 
the time of maximal response was highly variable 
between separate experiments (from 1 to 4 h) but 
in every case a slight up-regulation for B1R was 
observed that did not exceed 150% of the cell re-
sponse as compared to unstimulated cells (not 
shown). A more interesting observation was related 
to the augmentation of the B2R mRNA expression 
in PMA-differentiated cells by 1 nM DAKD. This 
increase achieved the maximal value (220%) after 
2 h of incubation (Fig. 3B). Thereafter, the amount 
of B2R mRNA strongly decreased (not shown). 
This effect was attenuated in RA-treated cells, with 
the augmentation of mRNA expression by ap-
prox. 150% above the unstimulated cell response 
value (Fig. 3B). The undifferentiated cells did not 
Figure 1. The effect of RA- or PMA-induced differentia-
tion of U937 cells on the kinin receptor gene expression.
The total RNA was isolated in cells before and after dif-
ferentiation with 1 µM RA or 25 nM PMA. The expression 
of B1R, B2R and GAPDH genes was analyzed by RT-PCR 
and the relative mRNA expression of kinin receptors was 
calculated as described under Materials and Methods. (A) 
The PCR products separated in agarose gel electrophoresis 
for undifferentiated cells (lane 1), after differentiation with 
RA (lane 2) or PMA (lane 3). (B) The calculated relative 
mRNA for kinin receptors in U937 cells before and after 
differentiation. Data points represent mean values ± stand-
ard deviation from at least three independent experiments. 
*P < 0.05 vs. undifferentiated cells.
Figure 2. The induction of kinin receptor mRNA in U937 
cells by bradykinin.
Cells after differentiation with 1 µM RA or 25 nM PMA 
or without differentiation were incubated with 1 nM BK. 
After RNA isolation the gene expression of B1R, B2R and 
GAPDH was analyzed by RT-PCR in separate samples 
every hour. The figures present the time dependent ex-
pression of B2R gene in undifferentiated cells (A), the rel-
ative B2R (B) and B1R (c) gene expression at the maximal 
cell response obtained after 2-hour incubation with BK as 
compared to unstimulated cells. The percentage of the re-
sponse was determined as described under Materials and 
Methods and expressed in relation to the values obtained 
for unstimulated cells (assumed to be 100%; not shown). 
Values are mean ± standard deviation from three inde-
pendent experiments. *P < 0.05 vs. unstimulated cells.
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show significant changes in B2R mRNA upon 1 nM 
DAKD incubation (Fig. 3B).
The regulation of kinin receptor expression 
by IL-1β was also analyzed. The effect of IL-1β on 
the augmentation of B2R mRNA was undisputable 
(Fig. 4A). The response to cytokine was detected 
already from the first 30 min of incubation and the 
maximum was achieved after 1-hour incubation. It 
was more intensive for RA- and PMA-differentiated 
cells (2-fold and 4-fold, respectively) as compared to 
unstimulated cells. The B2R up-regulation was pro-
longed even after 5 h of cytokine incubation with 
PMA-treated cells (not shown), when the percentage 
of induced mRNA is still high (200% in comparison 
to uninduced cells). On the other hand, a strong in-
duction of B1R gene was observed when PMA- and 
RA-differentiated cells were stimulated with IL-1β 
(370% and 140%, respectively) (Fig. 4A). The maxi-
mal response occurred after 1 h of stimulation and, 
similarly to the B2R receptor induction, this effect 
was only moderately decreased after 5 h. No sig-
nificant change in the mRNA level of this receptor 
was observed in undifferentiated cells after cytokine 
stimulation as compared to unstimulated cells.
The significant influence of IL-1β on mRNA 
augmentation of kinin receptors in U937 cells 
prompted us to investigate the effect of BK and 
DAKD on the induction of this cytokine. The kinin 
effect on the regulation of cytokine expression in 
U937 cells was poor (Fig. 4B). The kallidin metab-
olite, DAKD, seemed to be more effective in IL-1β 
expression in these cells. A weak increase was only 
observed in PMA-treated cells after stimulation with 
both 1 nM BK and 1 nM DAKD (by 130% and 150%, 
respectively). 
The expression of B1R, the inducible recep-
tor, was also investigated at the protein level by 
immunocytochemistry. Figure 5A shows the immu-
nocytochemical images obtained after incubation of 
the PMA-treated cells with BK, DAKD and IL-1β. 
The fluorescence signal derived from FITC-labeled 
antibody was more pronounced in stimulated cells 
compared to control cells. The quantitative analy-
sis of the obtained images is presented in Fig. 5B. 
Kinins and IL-1β, or these peptides in the presence 
of IL-1β, induced an increase in B1R protein on the 
PMA-treated cell surface. The level of this protein 
expression is similar in the studied samples, with the 
value 2 to 2.5 fold higher than that on the surface 
of unstimulated cells. The major production of B1R 
protein was observed for the incubation with DAKD 
and cytokine (above 2-fold). BK was also able to in-
Figure 3. The induction of kinin receptor mRNA in U937 
cells by dAKd.
Cells after RA- or PMA-differentiation or without differ-
entiation were stimulated with 1 nM DAKD. After RNA 
isolation the gene expression of B1R, B2R and GAPDH 
was analyzed by RT-PCR in separate samples every hour. 
The figures present the B1R (A) and B2R (B) mRNA ex-
pression at the maximal cell response achieved after 2 h 
in comparison to unstimulated cells. The percentage of the 
response was determined as described under Materials 
and Methods and expressed in relation to unstimulated 
cells (assumed to be 100%; not shown). Data points are 
mean ± standard deviation from three independent experi-
ments. *P < 0.05 vs. unstimulated cells.
Figure 4. The Il-1β role in the mRNA expression of ki-
nin receptors.
(A) Cells undifferentiated and after RA- or PMA differ-
entiation were incubated with 10 ng/ml IL-1β. After RNA 
isolation, the B1R, B2R and GAPDH expression was ana-
lyzed by RT-PCR. The figure shows the maximal cell re-
sponse achieved after 30-minute incubation for B2R and 
after 1-hour incubation for B1R. (B) Cells were incubated 
with BK or DAKD at 1 nM concentration and the expres-
sion of IL-1β and GAPDH mRNA was measured by RT-
PCR. The figure presents the maximal increase of cytokine 
gene expression reached after 1-hour or 2-hour incubation 
for differentiated or undifferentiated cells, respectively. 
The percentage of the response was determined as de-
scribed under Materials and Methods in relation to un-
stimulated cells (assumed to be 100%; not shown). Data 
are presented as means ± standard deviation from three 
independent experiments. *P < 0.05 vs. unstimulated cells.
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duce the B1R protein expression, though to a lesser 
extent as compared to the DAKD effect. In general, 
it seemed that the coincubation of kinins with IL-1β 
enhanced the increase in the amount of B1 receptors 
in investigated cells. 
dIscUssION
Mononuclear blood cells such as monocytes 
and macrophages exist in distinct stages of differen-
tiation and maturation. The U937 cell line, selected 
as the model for this study, showed diverse stages 
of differentiation like in mononuclear blood cells. 
After RA treatment we obtained non-adherent and 
non-prolifering cells, resembling the monocyte state 
while after stimulation with PMA the cells showed 
a higher adhesive capability like macrophages. The 
basal kinin receptor in these cells varied signifi-
cantly before and after differentiation. We found a 
constitutive B2R expression in undifferentiated cells, 
while B1R expression, though visible, was very low 
in the majority of the analyzed samples and a pos-
sible induction during sample processing cannot be 
excluded (Fig. 1). The effect of the differentiation 
agents on the B1R and B2R receptor expression al-
low us to suggest that cell maturation is accompa-
nied by an overexpression of these receptors, espe-
cially of B2R. The RA- and PMA-differentiation of 
U937 cells is associated with the increase of reactive 
oxygen species and cytokines, augmented enzymatic 
activity and changes in the cell membrane (Harris & 
Ralph, 1985), the effects which are likely to result in 
activation of the kinin receptor pathway.
Previous studies have demonstrated kinin 
binding to macrophages or the physiological re-
sponse of these cells to kinins but the kinin recep-
tor expression in monocytes or macrophages had 
not been extensively investigated. In this study, 
we focused on the investigation of the level of ki-
nin receptors after agonist treatment in the mono-
cyte/macrophage-liked cells. Our results clearly 
showed the induction of B2R mRNA expression in 
U937 cells by BK, independently of its differenti-
ated or undifferentiated state (Figs. 2A and 2B). 
In comparison to differentiated cells, the resting 
ones slowly but strongly produced B2R mRNA in 
response to BK. This can be related to the lower 
initial level of the receptor expression in undif-
ferentiated cells. The lower response of macro-
phage-like cells may be related to the relatively 
high heterogeneity of these cells displaying di-
verse differentiation or activation stages, including 
membrane integrin expression and phagocytosis 
after phorbol ester treatment (Hamada & Utiyama, 
2005). A stimulation of B1R receptor expression 
by its own agonist was observed in human fibrob-
lasts (Schanstra et al., 1998; Phagoo et al., 2001). 
Likewise, our study showed an increase of B1R 
mRNA in U937 cells after incubation with DAKD 
(Fig. 3A). The equivocal effect of this metabolite in 
PMA-treated cells may be also attributed to their 
high heterogeneity. Generally, we demonstrated 
that in monocyte- and macrophage-like cells, the 
regulation of B2R and B1R at the mRNA level by 
its own agonist is possible. Normally, B2R are 
regulated at the protein levels by internalizing to-
gether with the agonist molecule and by resensi-
tization (Leeb-Lundberg et al., 2005). The B1R are 
inducible and their expression on the cell surface 
may decrease. In these situations, the de novo syn-
thesis of the receptors after mRNA up-regulation 
by own agonists may be important in the pro-
longed inflammatory state.
Figure 5. The induction of B1R protein expression on 
PMA-differentiated U937 cells by kinins and Il-1β.
The cells were incubated for 6 h with 1 nM BK, 1 nM 
DAKD and 10 ng/ml IL-1β or with the peptides in the 
presence of IL-1β. A. Visualization of B1R receptor after 
cell stimulation. B. The fluorescence intensity was deter-
mined as described under Materials and Methods. AU, 
arbitrary units. Data are presented as mean ± standard 
deviation from three independent experiments. *P < 0.05 vs. 
control; & P < 0.05 vs. cells stimulated with IL-1β.
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The autoregulation of kinin receptors by ki-
nins was reported for the first time in human lung 
fibroblasts (Phagoo et al., 1999). These authors dem-
onstrated an induction of B1R gene with simultane-
ous decrease in B2R expression by kinins, especially 
in the presence of cytokines. In our study, the U937 
cell line also showed the B1R regulation by BK 
(Figs. 2 and 5) but the involvement of IL-1β in this 
regulation is not clear (Fig. 4B). Only the PMA-dif-
ferentiated cells showed a relatively low expression 
of the cytokine mRNA. In this work, in contrast to 
previous reports (Phagoo et al., 2000), an unexpect-
ed stimulatory effect of DAKD on B2R expression 
in PMA-treated U937 cells was detected (Fig. 3B). 
B2R is constitutively expressed, but several poten-
tial binding sites for transcription factors, such as 
NF-κB, have been identified on the gene promoter 
(Pesquero et al., 1996). Moreover, the induction of 
NF-κB by DAKD was proved in human IMR-90 
cells (Schanstra et al., 1998). Therefore, it can be pre-
sumed that B1R agonist could activate signal path-
ways, which quickly and intensively enhance the 
B2R gene transcription. The B2R gene induction by 
DAKD could play an important role in the mecha-
nism of autoregulation of kinin receptors, especially 
in the propagation of the inflammatory processes. 
Because the regulation of kinin receptor ex-
pression by cytokines in several cells has been ob-
served and the mononuclear cells are able to secrete 
these mediators, we proposed a contribution of cy-
tokines to the regulation of kinin receptor in U937 
cells. We selected IL-1β, a cytokine of the acute 
phase inflammation state which is secreted by mac-
rophages (Harris & Ralph, 1985; Rutherford et al., 
1993) to test this hypothesis. The majority of the 
papers related to the synergistic effect of IL-1β and 
kinins on leukocytes are concerned with free radical 
production, enhanced calcium transport or agonist 
binding by these cells (Bockmann et al., 1992; Bock-
mann & Paegelow, 1995). In this study we analyzed 
the mRNA expression of B1R and B2R upon IL-1β 
stimulation in U937 cell differentiated to monocytes 
or macrophages and in undifferentiated cells. As ex-
pected, we found that this cytokine caused a strong 
increase in mRNA of B2R (Fig. 4A). The obtained re-
sults showed an effective induction of B2R mRNA 
expression, with a positive regulation noted even 
in undifferentiated cells (by about 170%), as well as 
in RA- and PMA-treated cells (by about 200% and 
400%, respectively). The gene regulation of B1R by 
IL-1β was already demonstrated in a murine alveo-
lar macrophage cell line (Tsukagoshi et al., 1999). 
Our results also showed an up-regulation of B1R 
mRNA after IL-1β stimulation but only in PMA-dif-
ferentiated U937 cells. Probably, the cells at the dif-
ferentiated stage after PMA treatment could be more 
sensible to cytokine action. Summing up, although 
we did not observe a significant increase of mRNA 
expression of IL-1β induced by kinin-related pep-
tides, the participation of this cytokine in the kinin 
receptor expression was confirmed (Fig. 4A).
The regulation of B1R by BK, DAKD, and 
IL-1β was confirmed at the protein level (Fig. 5). A 
pronounced effect was obtained for the specific ago-
nist for B1R, DAKD alone or with the peptides in 
the presence of IL-1β. This observation validates the 
results obtained at the gene level, corroborating the 
hypothesis that IL-1β can enhance the B1R expres-
sion. Taken together, these results showed the regu-
lation of kinin receptors by kinins and their metab-
olites as well as by cytokines, such as IL-1β. Thus, 
the presence of these substances in injured tissues 
may prolong the kinin effects by the enhancement of 
their receptors. 
In summary, we demonstrated the constitutive 
expression of B2 receptors on promonocytic U937 
cell line as well as after differentiation to monocyte/
macrophage-like cells. The specific agonists were 
able to induce the expression of both kinin recep-
tors. In addition, an inflammation mediator, such as 
IL-1β can regulate the mRNA of both receptors and 
enhance their expression. Therefore kinins, through 
their receptors, can play an essential role in the im-
mune response. The enhancement of kinin receptor 
expression by IL-1β can contribute to prolonging the 
inflammation processes leading to development of 
the chronic state. Thus, pharmacological manipula-
tion of the B1 and B2 receptors opens new ways to 
the treatment of a wide range of diseases associated 
with the inflammatory responses. 
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